Unresectable Thymic Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-10-30
Clinical Trial Update: Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating carboplatin and paclitaxel with or without ramucirumab in thymic carcinoma has completed; results have been posted.